Stock Events

Stock Events

Quoin Pharmaceuticals 

$4.49
28
+$0.20+4.66% Friday 20:00

Statistics

Day High
4.69
Day Low
4.32
52W High
22.3
52W Low
4.29
Volume
20,015
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

9MayExpected
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-2.72
-1.81
-0.91
0
Expected EPS
-0.76
Actual EPS
-1.11

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-17.92MNet Income

Analyst Ratings

30.00Average Price Target
The highest estimate is 30.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow QNRX. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap149.21B
Pfizer is a global pharmaceutical company that competes with Quoin Pharmaceuticals in the development and marketing of medications across various therapeutic areas.
Johnson & Johnson
JNJ
Mkt Cap542.42B
Johnson & Johnson, through its pharmaceutical segment, competes in developing drugs that could directly compete with Quoin's product offerings.
Merck
MRK
Mkt Cap293.22B
Merck & Co., Inc. is involved in the discovery, development, manufacturing, and marketing of pharmaceuticals that can be in direct competition with Quoin Pharmaceuticals' products.
Abbvie
ABBV
Mkt Cap384.67B
AbbVie operates in similar therapeutic areas as Quoin Pharmaceuticals, making it a competitor in the pharmaceutical industry.
AMGEN
AMGN
Mkt Cap181.77B
Amgen is a biopharmaceutical company that competes with Quoin Pharmaceuticals in the development of innovative therapies.
Bristol-Myers Squibb
BMY
Mkt Cap116.77B
Bristol Myers Squibb is a global biopharmaceutical company whose range of products competes with those of Quoin Pharmaceuticals.
Gilead Sciences
GILD
Mkt Cap166.9B
Gilead Sciences is involved in the research and development of pharmaceuticals that could compete with Quoin Pharmaceuticals in certain therapeutic areas.
Novartis
NVS
Mkt Cap286.54B
Novartis is a global healthcare company that competes with Quoin Pharmaceuticals through its broad range of pharmaceutical products.
Roche
RHHBY
Mkt Cap337.5B
Roche Holding AG competes with Quoin Pharmaceuticals in the development and marketing of various pharmaceutical products.
Sanofi
SNY
Mkt Cap104.54B
Sanofi is a global pharmaceutical company that competes with Quoin Pharmaceuticals in several therapeutic areas, including rare diseases and immunology.

About

Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis. It also develops QRX008 for the treatment of scleroderma, which is in pre-clinical stage; and QRX009, to treat microcystic lymphatic malformations, venous malformations, angiofibroma, and other diseases. It has a research agreement with Queensland University of Technology. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.
Show more...
CEO
Dr. Michael Myers Ph.D.
Employees
3
Country
Israel
ISIN
US74907L4095

Listings

STU
DE
2EB0.STU
BOATS
BOATS
QNRX.BOATS
F
DE
2EB0.F
XNAS
US
QNRX

0 Comments

Share your thoughts

FAQ

What is Quoin Pharmaceuticals stock price today?▼
The current price of QNRX is $4.49 USD — it has increased by +4.66% in the past 24 hours. Watch Quoin Pharmaceuticals stock price performance more closely on the chart.
What is Quoin Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Quoin Pharmaceuticals stocks are traded under the ticker QNRX.
Is Quoin Pharmaceuticals stock price growing?▼
QNRX stock has fallen by -11.26% compared to the previous week, the month change is a -29.51% fall, over the last year Quoin Pharmaceuticals has showed a -49.09% decrease.
What were Quoin Pharmaceuticals earnings last quarter?▼
QNRX earnings for the last quarter are -1.11 USD per share, whereas the estimation was -0.76 USD resulting in a -46.05% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Quoin Pharmaceuticals revenue for the last year?▼
Quoin Pharmaceuticals revenue for the last year amounts to 0 USD.
What is Quoin Pharmaceuticals net income for the last year?▼
QNRX net income for the last year is -17.92M USD.
How many employees does Quoin Pharmaceuticals have?▼
As of June 07, 2026, the company has 3 employees.
In which sector is Quoin Pharmaceuticals located?▼
Quoin Pharmaceuticals operates in the Health & Wellness sector.
When did Quoin Pharmaceuticals complete a stock split?▼
The last stock split for Quoin Pharmaceuticals was on April 09, 2025 with a ratio of 1:35.
Where is Quoin Pharmaceuticals headquartered?▼
Quoin Pharmaceuticals is headquartered in Ashburn, Israel.